Sponsor study identifier
Secondary identifiers
observational
95
1 country
3
Study Start
July 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2009
Actual (reported)Study Completion
April 2010
Actual (reported)RATIONALE: Studying blood or mouthwash samples in the laboratory from patients receiving melphalan for cancer may help doctors learn more about changes that occur in DNA, identify biomarkers related to cancer, and help predict how patients will respond to treatment. PURPOSE: This clinical trial is studying common genetic mutations related to mucositis in patients with multiple myeloma receiving high-dose melphalan.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 2010
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 2007
Date type not reportedThis date has not been verified as actual or estimated.
January 22, 2008
Actual (reported)January 28, 2008
Actual (reported)January 2009
Actual (reported)April 2010
Actual (reported)Association between single nucleotide polymorphisms (SNPs) in genes that encode the melphalan transporters and development and/or severity of mucositis
4 weeks
Association between SNPs in genes that influence melphalan metabolism and development and/or severity of mucositis
4 weeks
People who have been diagnosed with multiple myeloma and have received high-dose melphalan.
People who have been diagnosed with multiple myeloma and will be receiving high-dose melphalan.
Blood or cheek cells wil be collected.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
People who have been diagnosed with multiple myeloma and have received or will be receiving high-dose melphalan.
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Vanderbilt-Ingram Cancer Center at Franklin
Nashville, Tennessee, 37064, United States
Veterans Affairs Medical Center - Nashville
Nashville, Tennessee, 37212, United States
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232-6838, United States
Blood sample or cheek cells will be collected.
Stephen Brandt, MD
Vanderbilt-Ingram Cancer Center
95 participants (actual enrollment reported by the registry).
First Submitted
January 22, 2008
First Posted
January 28, 2008
Study Start
July 2007
Date type not reportedThis date has not been verified as actual or estimated.
Studying Tumor Samples From Young Patients With Neuroblastoma
Primary Completion
January 2009
Actual (reported)Study Completion
April 2010
Actual (reported)Last Updated
March 14, 2013
Record last verified: 2013-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: